An observational study in Lumbar Degenerative Disease, sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2024-07-17.
Sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Observational
The study aimed to compare the clinical efficacy and safety of unilateral biportal endoscopic lumbar interbody fusion (ULIF) with posterior lumbar interbody fusion (PLIF) in the treatment of single-level lumbar degenerative diseases.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University is the lead sponsor of 466 studies on the registry; 271 are open to participants now.
Counted across the registry records on this site, refreshed daily.
(3) The patient is undergoing their initial single-segment ULIF or PLIF surgery at our hospital.
Exclusion Criteria:
Unilateral Biportal Endoscopy Lumbar Interbody Fusion
Posterior Lumbar Interbody Fusion
ODI
Oswestry Disability Index
Time frame: before surgery,1-week,1-month,3-month,6-month and 1-year postoperative
This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University